Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

被引:27
|
作者
Zhao, Wan-Hong [1 ]
Liu, Jie [1 ]
Wang, Bai-Yan [1 ]
Chen, Yin-Xia [1 ]
Cao, Xing-Mei [1 ]
Yang, Yun [1 ]
Zhang, Yi-Lin [1 ]
Wang, Fang-Xia [2 ]
Zhang, Peng-Yu [1 ]
Lei, Bo [1 ]
Gu, Liu-Fang [1 ]
Wang, Jian-Li [1 ]
Yang, Nan [1 ]
Zhang, Ru [1 ]
Zhang, Hui [1 ]
Shen, Ying [1 ]
Bai, Ju [1 ]
Xu, Yan [1 ]
Wang, Xu-Geng [1 ]
Zhang, Rui-Li [1 ]
Wei, Li-Li [1 ]
Li, Zong-Fang [3 ]
Li, Zhen-Zhen [3 ]
Geng, Yan [4 ]
He, Qian [4 ]
Zhuang, Qiu-Chuan [5 ]
Fan, Frank Xiao-Hu [5 ]
He, Ai-Li [1 ,3 ]
Zhang, Wang-Gang [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Hematol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China
[4] Xi An Jiao Tong Univ, Dept Clin Lab, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China
[5] Nanjing Legend Biotech, Nanjing, Jiangsu, Peoples R China
关键词
D O I
10.1182/blood-2018-99-110548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
955
引用
收藏
页数:4
相关论文
empty
未找到相关数据